Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Gossamer Bio, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 120 | 111 | −9 |
| Shares | 103.8M | 77.7M | −26.1M (−25.1%) |
| Value | $225.1M | $97.9M | −$127.3M (−56.5%) |
New holders (24)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (33)
Institutions that held Gossamer Bio, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.